vimarsana.com

Page 29 - தடுப்பூசி விநியோகி நுழைவு உத்தரவாதம் சிறப்பு குழு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

MOH mulls giving blood donors priority in next vaccination phase

MOH mulls giving blood donors priority in next vaccination phase 09 Apr 2021 / 19:57 H. Pix for illustration purposes. KUALA LUMPUR: The Health Ministry (MOH) is looking into a proposal that those who have donated blood more than 50 times be given priority in the second phase of the National Covid-19 Immunisation Programme. Health Minister Datuk Seri Dr Adham Baba said the MOH will raise the matter with the Covid-19 Vaccine Supply Access Guarantee Special Committee. “It is actually a good proposal and an incentive for blood donors in the country,” he told a media conference after a visit to the National Blood Centre (PDN) here today.

Govt to review use of AstraZeneca vaccine following EMA findings, says Khairy

KUALA LUMPUR (April 8): Malaysia will review the use of the AstraZeneca Covid-19 vaccine in the country following the European Medicines Agency s (EMA) findings that unusual blood clots with low blood platelets should be listed as very rare side effects of the vaccine. Coordinating Minister for the National Covid-19 Immunisation Programme Khairy Jamaluddin said the Covid-19 Vaccine Supply Access Guarantee Special Committee (JKJAV) will deliberate on the matter. “We take note of the EMA’s announcement on the AstraZeneca vaccine. JKJAV will deliberate on the matter and decide if we will go ahead with using AZ (AstraZeneca) in our portfolio of vaccines. Safety is paramount,” he said in his tweet today.

Malaysia to review use of AstraZeneca vaccine following EMA findings

Malaysia to review use of AstraZeneca vaccine following EMA findings 08 Apr 2021 / 13:01 H. -Bernama KUALA LUMPUR: Malaysia will review the use of the AstraZeneca Covid-19 vaccine in the country following the European Medicines Agency’s (EMA) findings that unusual blood clots with low blood platelets should be listed as very rare side effects of the vaccine. Coordinating Minister for the National Covid-19 Immunisation Programme Khairy Jamaluddin (pix) said the Covid-19 Vaccine Supply Access Guarantee Special Committee (JKJAV) will deliberate on the matter. “We take note of EMA’s announcement on the AstraZeneca vaccine. JKJAV will deliberate on the matter and decide if we will go ahead with using AZ (AstraZeneca) in our portfolio of vaccines. Safety is paramount,” he said in his tweet today.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.